Cargando…
Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?
Immunochemical faecal occult blood tests have shown a greater sensitivity than guaiac test in colorectal cancer screening, but optimal number of samples and cutoff have still to be defined. The aim of this multicentric study was to evaluate the performance of immunochemical-based screening strategie...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634712/ https://www.ncbi.nlm.nih.gov/pubmed/19142185 http://dx.doi.org/10.1038/sj.bjc.6604864 |
_version_ | 1782164149429600256 |
---|---|
author | Grazzini, G Visioli, C B Zorzi, M Ciatto, S Banovich, F Bonanomi, A G Bortoli, A Castiglione, G Cazzola, L Confortini, M Mantellini, P Rubeca, T Zappa, M |
author_facet | Grazzini, G Visioli, C B Zorzi, M Ciatto, S Banovich, F Bonanomi, A G Bortoli, A Castiglione, G Cazzola, L Confortini, M Mantellini, P Rubeca, T Zappa, M |
author_sort | Grazzini, G |
collection | PubMed |
description | Immunochemical faecal occult blood tests have shown a greater sensitivity than guaiac test in colorectal cancer screening, but optimal number of samples and cutoff have still to be defined. The aim of this multicentric study was to evaluate the performance of immunochemical-based screening strategies according to different positivity thresholds (80, 100, 120 ng ml(−1)) and single vs double sampling (one, at least one, or both positive samples) using 1-day sample with cutoff at 100 ng ml(−1) as the reference strategy. A total of 20 596 subjects aged 50–69 years were enrolled from Italian population-based screening programmes. Positivity rate was 4.5% for reference strategy and 8.0 and 2.0% for the most sensitive and the most specific strategy, respectively. Cancer detection rate of reference strategy was 2.8‰, and ranged between 2.1 and 3.4‰ in other strategies; reference strategy detected 15.6‰ advanced adenomas (range=10.0–22.5‰). The number needed to scope to find a cancer or an advanced adenoma was lower than 2 (1.5–1.7) for the most specific strategies, whereas it was 2.4–2.7, according to different thresholds, for the most sensitive ones. Different strategies seem to have a greater impact on adenomas rather than on cancer detection rate. The study provides information when deciding screening protocols and to adapt them to local resources. |
format | Text |
id | pubmed-2634712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-26347122010-01-27 Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Grazzini, G Visioli, C B Zorzi, M Ciatto, S Banovich, F Bonanomi, A G Bortoli, A Castiglione, G Cazzola, L Confortini, M Mantellini, P Rubeca, T Zappa, M Br J Cancer Clinical Study Immunochemical faecal occult blood tests have shown a greater sensitivity than guaiac test in colorectal cancer screening, but optimal number of samples and cutoff have still to be defined. The aim of this multicentric study was to evaluate the performance of immunochemical-based screening strategies according to different positivity thresholds (80, 100, 120 ng ml(−1)) and single vs double sampling (one, at least one, or both positive samples) using 1-day sample with cutoff at 100 ng ml(−1) as the reference strategy. A total of 20 596 subjects aged 50–69 years were enrolled from Italian population-based screening programmes. Positivity rate was 4.5% for reference strategy and 8.0 and 2.0% for the most sensitive and the most specific strategy, respectively. Cancer detection rate of reference strategy was 2.8‰, and ranged between 2.1 and 3.4‰ in other strategies; reference strategy detected 15.6‰ advanced adenomas (range=10.0–22.5‰). The number needed to scope to find a cancer or an advanced adenoma was lower than 2 (1.5–1.7) for the most specific strategies, whereas it was 2.4–2.7, according to different thresholds, for the most sensitive ones. Different strategies seem to have a greater impact on adenomas rather than on cancer detection rate. The study provides information when deciding screening protocols and to adapt them to local resources. Nature Publishing Group 2009-01-27 2009-01-13 /pmc/articles/PMC2634712/ /pubmed/19142185 http://dx.doi.org/10.1038/sj.bjc.6604864 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Study Grazzini, G Visioli, C B Zorzi, M Ciatto, S Banovich, F Bonanomi, A G Bortoli, A Castiglione, G Cazzola, L Confortini, M Mantellini, P Rubeca, T Zappa, M Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? |
title | Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? |
title_full | Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? |
title_fullStr | Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? |
title_full_unstemmed | Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? |
title_short | Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? |
title_sort | immunochemical faecal occult blood test: number of samples and positivity cutoff. what is the best strategy for colorectal cancer screening? |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634712/ https://www.ncbi.nlm.nih.gov/pubmed/19142185 http://dx.doi.org/10.1038/sj.bjc.6604864 |
work_keys_str_mv | AT grazzinig immunochemicalfaecaloccultbloodtestnumberofsamplesandpositivitycutoffwhatisthebeststrategyforcolorectalcancerscreening AT visiolicb immunochemicalfaecaloccultbloodtestnumberofsamplesandpositivitycutoffwhatisthebeststrategyforcolorectalcancerscreening AT zorzim immunochemicalfaecaloccultbloodtestnumberofsamplesandpositivitycutoffwhatisthebeststrategyforcolorectalcancerscreening AT ciattos immunochemicalfaecaloccultbloodtestnumberofsamplesandpositivitycutoffwhatisthebeststrategyforcolorectalcancerscreening AT banovichf immunochemicalfaecaloccultbloodtestnumberofsamplesandpositivitycutoffwhatisthebeststrategyforcolorectalcancerscreening AT bonanomiag immunochemicalfaecaloccultbloodtestnumberofsamplesandpositivitycutoffwhatisthebeststrategyforcolorectalcancerscreening AT bortolia immunochemicalfaecaloccultbloodtestnumberofsamplesandpositivitycutoffwhatisthebeststrategyforcolorectalcancerscreening AT castiglioneg immunochemicalfaecaloccultbloodtestnumberofsamplesandpositivitycutoffwhatisthebeststrategyforcolorectalcancerscreening AT cazzolal immunochemicalfaecaloccultbloodtestnumberofsamplesandpositivitycutoffwhatisthebeststrategyforcolorectalcancerscreening AT confortinim immunochemicalfaecaloccultbloodtestnumberofsamplesandpositivitycutoffwhatisthebeststrategyforcolorectalcancerscreening AT mantellinip immunochemicalfaecaloccultbloodtestnumberofsamplesandpositivitycutoffwhatisthebeststrategyforcolorectalcancerscreening AT rubecat immunochemicalfaecaloccultbloodtestnumberofsamplesandpositivitycutoffwhatisthebeststrategyforcolorectalcancerscreening AT zappam immunochemicalfaecaloccultbloodtestnumberofsamplesandpositivitycutoffwhatisthebeststrategyforcolorectalcancerscreening |